Equity
TRADEMED has made a profit in every financial year since 2015.
The dashed line is the sector median: 0.6% across 40,277 companies (NACE 47, micro).
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 56% of them on solvency, 31% on liquidity, 37% on profitability and 57% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 10,904 companies had the same profile as TRADEMED has now. Each dot stands for 28 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of TRADEMED itself is higher: 1.1% within 12 months. It rests on far more data about TRADEMED than the profile alone.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 10,904 companies, not a prediction for TRADEMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is ample, with a current ratio of 1.95 (1.96 in 2024), above the usual 1.5. Short-term debt is 51% and cash 7.4% of total assets. However, 59.2% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 7 accounts on average 58 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| TRADEMED Saint-Josse-ten-Noode | €378,205 | €190,096 | 40.8% | - |
| TAYBA TRADING Anderlecht | €408,894 | €187,251 | 15.0% | - |
| BELTUNA Schaerbeek | €332,569 | €143,328 | 11.9% | - |
| BELDIX Chaumont-Gistoux | €367,150 | €180,916 | 33.4% | 0.6 |
| ERGUN'S MARKET Ghent | €383,631 | €163,046 | 67.4% | - |
| PEKSOY Charleroi | €394,730 | €162,280 | 63.4% | - |
| S&Y GROUP Grimbergen | €421,063 | €209,831 | 5.4% | 5.7 |
These companies have the same main activity as TRADEMED: non-specialised retail sale with food, beverages or tobacco predominating (NACE 47110). They are comparable in size and age: total assets between €333,000 and €421,000, founded between 2014 and 2016.
TRADEMED files the abbreviated format. That format states no turnover. The gross margin rose from €51,960 in 2015 to €190,096 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
The turnover shown is an estimate from the gross margin.
Turnover ≈ €1.7m. Estimated: probably between €1.2m and €2.3m.
Higher than 55% of 12,856 companies in 2025.
Higher than 62% of 12,646 companies in 2025.
Higher than 43% of 12,719 companies in 2025.
Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half · Staff: middle half
Staff costs divided by the average number of full-time equivalents.
| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||||||
20/58 |
378,205 | 410,252 | 485,089 | 517,388 | 743,349 | 753,539 | 960,094 | 867,598 | 769,566 | 703,072 | 332,195 | |
20 |
- | - | - | - | - | - | - | 280 | 560 | 840 | 1,120 | |
21/28 |
2,235 | 18,369 | 34,416 | 51,189 | 82,042 | 66,785 | 101,292 | 137,021 | 173,446 | 163,683 | 29,479 | |
21 |
- | - | 2,000 | 4,000 | 6,000 | 8,000 | 10,360 | 12,720 | 15,080 | 17,440 | 18,000 | |
22/27 |
2,235 | 18,369 | 32,416 | 47,189 | 76,042 | 58,785 | 90,932 | 124,301 | 158,366 | 145,986 | 10,102 | |
23 |
- | 9,973 | 19,945 | 29,918 | 39,890 | 49,863 | 60,236 | 71,076 | 81,917 | 92,758 | 1,872 | |
24 |
- | 5,315 | 8,542 | 17,271 | 36,151 | 822 | 4,246 | 7,220 | 10,889 | 8,613 | 3,409 | |
26 |
2,235 | 3,082 | 3,929 | - | - | - | 1,660 | 4,525 | 7,390 | 10,255 | 4,821 | |
28 |
- | - | - | - | - | - | - | - | - | 257 | 257 | |
29/58 |
375,971 | 391,883 | 450,673 | 466,199 | 661,307 | 686,754 | 858,802 | 730,297 | 595,560 | 538,549 | 302,716 | |
29 |
- | - | - | - | - | - | 156,060 | 153,000 | - | - | - | |
291 |
- | - | - | - | - | - | 156,060 | 153,000 | - | - | - | |
3 |
210,678 | 315,552 | 346,329 | 412,095 | 396,943 | 465,620 | 431,235 | 259,173 | 181,185 | 287,857 | 235,860 | |
30/36 |
210,678 | 315,552 | 346,329 | 412,095 | 396,943 | 465,620 | 431,235 | 259,173 | 181,185 | 287,857 | 235,860 | |
40/41 |
135,977 | 49,269 | 95,553 | 50,771 | 241,288 | 206,670 | 251,561 | 298,419 | 384,996 | 218,659 | 58,225 | |
40 |
128,682 | 44,830 | 95,442 | 46,977 | 240,174 | 202,002 | 241,321 | 294,440 | 384,996 | 218,659 | 46,279 | |
41 |
7,295 | 4,438 | 111 | 3,793 | 1,114 | 4,668 | 10,240 | 3,979 | - | - | 11,946 | |
50/53 |
0 | - | - | - | - | - | - | - | - | - | - | |
54/58 |
28,112 | 26,076 | 7,289 | 1,137 | 19,248 | 13,607 | 18,285 | 17,542 | 23,997 | 29,289 | 8,420 | |
490/1 |
1,203 | 986 | 1,501 | 2,198 | 3,829 | 857 | 1,661 | 2,163 | 5,382 | 2,744 | 211 | |
| Balance sheet: equity and liabilities | ||||||||||||
10/49 |
378,205 | 410,252 | 485,089 | 517,388 | 743,349 | 753,539 | 960,094 | 867,598 | 769,566 | 703,072 | 332,195 | |
10/15 |
154,220 | 142,970 | 129,422 | 103,505 | 88,998 | 87,087 | 82,613 | 77,633 | 55,493 | 37,720 | 12,224 | |
10/11 |
6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | |
10 |
6,200 | - | - | - | 6,200 | - | - | - | - | - | - | |
100 |
18,600 | - | - | - | 18,600 | 18,600 | 18,600 | 18,600 | 18,600 | 18,600 | 18,600 | |
101 |
12,400 | - | - | - | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | 12,400 | |
11 |
- | - | 6,200 | 6,200 | - | - | - | - | - | - | - | |
1109/19 |
- | - | 6,200 | 6,200 | - | - | - | - | - | - | - | |
13 |
1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,576 | 301 | |
130/1 |
1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | - | - | - | - | - | |
130 |
- | - | - | - | 1,860 | 1,860 | 1,860 | 1,860 | 1,860 | 1,576 | 301 | |
1311 |
1,860 | 1,860 | 1,860 | 1,860 | - | - | - | - | - | - | - | |
14 |
146,160 | 134,910 | 121,362 | 95,445 | 80,938 | 79,027 | 74,553 | 69,573 | 47,433 | 29,944 | 5,723 | |
17/49 |
223,985 | 267,282 | 355,667 | 413,883 | 654,351 | 666,452 | 877,481 | 789,965 | 714,073 | 665,352 | 319,971 | |
17 |
31,011 | 67,219 | 102,363 | 136,472 | 375,000 | 380,865 | 451,380 | 478,971 | 484,882 | 267,995 | - | |
170/4 |
31,011 | 67,219 | 102,363 | 136,472 | 375,000 | 380,865 | 451,380 | 478,971 | 484,882 | 267,995 | - | |
42/48 |
192,974 | 200,062 | 253,304 | 276,061 | 279,351 | 284,037 | 415,351 | 308,544 | 227,960 | 397,222 | 319,971 | |
42 |
36,209 | 45,143 | 44,109 | 43,106 | 10,000 | 27,213 | 36,758 | 35,877 | 35,008 | 6,392 | - | |
43 |
5 | 5 | - | - | - | 6 | 5 | 10 | 18,010 | 13,226 | - | |
430/8 |
5 | 5 | - | - | - | 6 | 5 | 10 | 18,010 | 13,226 | - | |
44 |
114,667 | 114,309 | 168,305 | 181,441 | 202,712 | 192,166 | 309,728 | 253,000 | 147,162 | 331,406 | 225,076 | |
440/4 |
114,667 | 114,309 | 168,305 | 181,441 | 202,712 | 192,166 | 309,728 | 253,000 | 147,162 | 331,406 | 225,076 | |
46 |
- | - | - | - | - | 20,619 | 1,736 | - | - | - | - | |
45 |
30,553 | 29,065 | 28,509 | 39,134 | 57,846 | 43,103 | 65,140 | 17,443 | 27,776 | 42,247 | 15,626 | |
450/3 |
9,836 | 6,007 | 3,915 | 11,504 | 19,914 | 2,285 | - | 990 | 6,593 | 26,364 | 5,093 | |
454/9 |
20,717 | 23,057 | 24,594 | 27,630 | 37,931 | 40,818 | 65,140 | 16,453 | 21,183 | 15,883 | 10,533 | |
47/48 |
11,540 | 11,540 | 12,380 | 12,380 | 8,793 | 930 | 1,984 | 2,214 | 4 | 3,951 | 79,269 | |
492/3 |
- | - | - | 1,350 | - | 1,550 | 10,750 | 2,450 | 1,231 | 135 | - | |
| Income statement | ||||||||||||
76A |
- | - | - | - | - | 59,507 | - | - | - | - | - | |
9900 |
190,096 | 205,899 | 219,228 | 240,005 | 282,234 | 284,449 | 362,469 | 387,321 | 294,018 | 172,106 | 51,960 | |
62 |
147,184 | 156,794 | 144,324 | 180,077 | 200,943 | 283,527 | 290,975 | 278,936 | 188,092 | 104,578 | 35,273 | |
630 |
10,820 | 16,047 | 15,507 | 21,185 | 16,413 | 31,905 | 36,011 | 36,704 | 36,684 | 28,771 | 4,805 | |
640/8 |
4,539 | 2,688 | 2,350 | 3,761 | 39,814 | 5,145 | 10,341 | 18,354 | 9,984 | 2,853 | 191 | |
66A |
- | - | - | - | - | - | - | - | 190 | - | - | |
9901 |
27,554 | 30,369 | 57,047 | 34,981 | 25,064 | -36,128 | 25,142 | 53,327 | 59,258 | 35,904 | 11,691 | |
75/76B |
705 | 2,228 | 1,495 | 4,266 | 8,103 | 69,358 | 4,399 | 12,369 | 454 | 836 | 267 | |
75 |
705 | 2,228 | 1,495 | 1,700 | 8,103 | 9,851 | 4,399 | 12,369 | 454 | 836 | 267 | |
76B |
- | - | - | 2,567 | - | 59,507 | - | - | - | - | - | |
65/66B |
10,975 | 13,488 | 9,333 | 18,534 | 15,709 | 19,870 | 18,115 | 37,409 | 30,909 | 5,670 | 841 | |
65 |
10,975 | 13,488 | 9,333 | 18,534 | 15,709 | 19,870 | 18,115 | 37,409 | 30,719 | 5,670 | 841 | |
66B |
- | - | - | - | - | - | - | - | 190 | - | - | |
9903 |
17,284 | 19,109 | 49,209 | 20,714 | 17,458 | 13,360 | 11,426 | 28,287 | 28,803 | 31,070 | 11,117 | |
67/77 |
6,034 | 5,562 | 23,292 | 6,207 | 15,548 | 8,886 | 6,446 | 6,147 | 11,030 | 5,574 | 5,093 | |
9904 |
11,250 | 13,548 | 25,917 | 14,507 | 1,910 | 4,474 | 4,980 | 22,140 | 17,773 | 25,496 | 6,024 | |
9905 |
11,250 | 13,548 | 25,917 | 14,507 | 1,910 | 4,474 | 4,980 | 22,140 | 17,773 | 25,496 | 6,024 | |
| Appropriation of the result | ||||||||||||
9906 |
146,160 | 134,910 | 121,362 | 95,445 | 80,938 | 79,027 | 74,553 | 69,573 | 47,717 | 31,219 | 6,024 | |
14P |
134,910 | 121,362 | 95,445 | 80,938 | 79,028 | - | - | - | - | - | - | |
691/2 |
- | - | - | - | - | - | - | - | 284 | 1,275 | 301 | |
6920 |
- | - | - | - | - | - | - | - | 284 | 1,275 | 301 | |
| Social balance sheet | ||||||||||||
9087 |
3.3 | - | - | - | 5 | 7 | 9 | 9 | 6 | 3 | 2 | |
Hours worked1013 |
5,653 | - | - | - | 9,036 | 12,042 | 15,216 | 15,317 | 10,694 | 7,433 | 2,354 | |
| Document | ||||||||||||
The notes to these accounts have 8 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 08-10-2026.
2025 annual accounts filed 69 days after the deadline. Filed on 8 October 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00552912.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | abbreviated format | 08-10-2026 | 2026-00552912 | |
| 31-12-2024 | micro format | 26-09-2025 | 2025-00519105 | |
| 31-12-2023 | micro format | 05-10-2024 | 2024-00499841 | |
| 31-12-2022 | micro format | 01-09-2023 | 2023-00427006 | |
| 31-12-2021 | full format | 30-08-2022 | 2022-20409476 | |
| 31-12-2020 | full format | 30-09-2021 | 2021-70000463 | |
| 31-12-2019 | full format | 30-10-2020 | 2020-66900386 | |
| 31-12-2018 | full format | 26-09-2019 | 2019-66200043 | |
| 31-12-2017 | full format | 21-09-2018 | 2018-64000025 | |
| 31-12-2016 | full format | 22-05-2017 | 2017-12800014 | |
| 31-12-2015 | full format | 04-07-2016 | 2016-27400462 |
| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38,373 | 46,416 | 72,553 | 56,167 | 41,477 | -4,223 | 61,153 | 90,031 | 95,942 | 64,675 | 16,496 | ||
| 22,070 | 29,595 | 41,424 | 35,692 | 18,324 | 36,379 | 40,991 | 58,844 | 54,457 | 54,267 | 10,829 | ||
| -5,315 | 0 | 4,235 | 4,295 | 39,769 | -2,602 | 282 | 279 | 51,114 | 163,815 | 32,884 | ||
| 2,037 | 18,786 | 6,153 | -18,111 | 5,641 | -4,678 | 743 | -6,455 | -5,292 | 20,869 | - | ||
| 182,997 | 191,821 | 197,369 | 190,138 | 381,956 | 402,717 | 443,451 | 421,753 | 367,600 | 141,327 | -17,255 | ||
| 40.8% | 34.8% | 26.7% | 20.0% | 12.0% | 11.6% | 8.6% | 8.9% | 7.2% | 5.4% | 3.7% | ||
| 1.95 | 1.96 | 1.78 | 1.69 | 2.37 | 2.42 | 2.07 | 2.37 | 2.61 | 1.36 | 0.95 | ||
| 0.86 | 0.38 | 0.41 | 0.20 | 0.95 | 0.78 | 1.03 | 1.53 | 1.82 | 0.63 | 0.21 | ||
| 1.45 | 1.87 | 2.75 | 4.00 | 7.35 | 7.65 | 10.62 | 10.18 | 12.87 | 17.64 | 26.18 | ||
| 7.3% | 9.5% | 20.0% | 14.0% | 2.1% | 5.1% | 6.0% | 28.5% | 32.0% | 67.6% | 49.3% | ||
| 3.0% | 3.3% | 5.3% | 2.8% | 0.3% | 0.6% | 0.5% | 2.6% | 2.3% | 3.6% | 1.8% | ||
| 3.50 | 3.44 | 7.77 | 3.03 | 2.64 | - | - | - | - | - | - |
EBIT margin: not included in this filing.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
| Item | 31-12-2025 | 31-12-2021 |
|---|---|---|
| Employees at the balance-sheet date | 4 | 6 |
| full-time | 3 | 3 |
| part-time | 1 | 3 |
| in full-time equivalents | 3.3 | 4.8 |
| 3.3 | 5.2 | |
| On a permanent contract | 3 | 6 |
| Joined | - | 0 |
| Left | - | 1 |
Source: social balance sheet in the 2021 to 2025 annual accounts
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | - | €4,235 | €4,295 | €39,769 |
| €10,820 | €16,047 | €15,507 | €21,185 | €16,413 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
The operating result for 2025 is 9% lower than in 2024 and the lowest since 2021. It is the second fall in a row.
Debt's share of the balance-sheet total falls from 65.2% to 59.2%. Equity is higher and debt is lower.
TRADEMED has no parent and no holdings in its annual accounts. KRIAKOS ACADIA is the only director. TRADEMED shares no director with another company.
| ACM COMPANY
registered office since 19-07-2024 · founded in 2024 · negative equity (2025) |
total assets €22,976 (2025) 1011.775.128 |
Deadline for the 2026 accounts: 31-07-2027
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
| Establishment | Since | Unit number | FASFC approval |
|---|---|---|---|
| Leuvensesteenweg 166 1210 Saint-Josse-ten-Noode | 06-02-2015 | 2.239.288.550 | |
| Leuvensesteenweg 168 1210 Saint-Josse-ten-Noode | 01-12-2015 | 2.248.212.253 | Retail trade |
| Leuvensesteenweg 170 registered office 1210 Saint-Josse-ten-Noode | 01-12-2015 | 2.248.212.352 |
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 21572B0085/00C003 | 208 m² | 1 · 200 m² | 18.0 m · 1 |
| 21572B0085/00Z002 | 105 m² | - | - |
| 21572B0085/00K002 | 82 m² | 1 · 89 m² | 15.1 m · 5 |
If something looks wrong or is missing, please tell us.